Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP869668.RAyGULzvNbFGEU_ZwYxhiK0O61phZWPsiDTpSXuZF5DVs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869668.RAyGULzvNbFGEU_ZwYxhiK0O61phZWPsiDTpSXuZF5DVs130_assertion type Assertion NP869668.RAyGULzvNbFGEU_ZwYxhiK0O61phZWPsiDTpSXuZF5DVs130_head.
- NP869668.RAyGULzvNbFGEU_ZwYxhiK0O61phZWPsiDTpSXuZF5DVs130_assertion description "[Patients with HER2-positive breast tumors (HER2 score of 3+ by immunohistochemistry or positive for HER2 amplification by fluorescence in situ hybridization (FISH)) (n = 86) and with HER2-negative breast tumors (n = 40) (negative controls) were included in this study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869668.RAyGULzvNbFGEU_ZwYxhiK0O61phZWPsiDTpSXuZF5DVs130_provenance.
- NP869668.RAyGULzvNbFGEU_ZwYxhiK0O61phZWPsiDTpSXuZF5DVs130_assertion evidence source_evidence_literature NP869668.RAyGULzvNbFGEU_ZwYxhiK0O61phZWPsiDTpSXuZF5DVs130_provenance.
- NP869668.RAyGULzvNbFGEU_ZwYxhiK0O61phZWPsiDTpSXuZF5DVs130_assertion SIO_000772 21288332 NP869668.RAyGULzvNbFGEU_ZwYxhiK0O61phZWPsiDTpSXuZF5DVs130_provenance.
- NP869668.RAyGULzvNbFGEU_ZwYxhiK0O61phZWPsiDTpSXuZF5DVs130_assertion wasDerivedFrom befree-2016 NP869668.RAyGULzvNbFGEU_ZwYxhiK0O61phZWPsiDTpSXuZF5DVs130_provenance.
- NP869668.RAyGULzvNbFGEU_ZwYxhiK0O61phZWPsiDTpSXuZF5DVs130_assertion wasGeneratedBy ECO_0000203 NP869668.RAyGULzvNbFGEU_ZwYxhiK0O61phZWPsiDTpSXuZF5DVs130_provenance.